중증 질환에서 호르몬의 변화 = Hormonal Changes in Critical Condition

다국어 초록 (Multilingual Abstract)

When disease or trauma progresses to a critical state, the reaction of the endocrine system in creating homeostasis is essential for survival. The association between the severity of hormonal changes and outcome in terms of morbidity and mortality has led to the challenge of development of several endocrine treatments. During sepsis, nitric oxide-mediated apoptosis is observed in the neurons and glial cells of the cerebrovascular centers of the autonomic nervous system. It is probably one of the components of the circulatory dysfunction of sepsis. The regulation of different organs was neither linear nor independent however organs were found to behave as biological oscillators coupled to each other through neurological or hormonal communication pathways. Sepsis, because of systemic inflammatory responsive syndrome, disrupts these communication pathways and leads to organ failures. Endocrine hormonal issues related to the intensive care setting are common challenges to ICU specialists. Disruptions of the endocrine system in sepsis are characterized by 1) an increase in cortisol plasma levels with a loss of the circadian rhythm of its secretion; 2) hyperglycemia due to insulin resistance and rise in hyperglycemic hormones secretion; 3)relative vasopressin deficiency; and 4) euthyroid sick syndrome or non-thyroidal illness syndrome. This article discusses the dynamic changes of four main endocrine axes: hypothalamic-pituitary-adrenal axis, insulin, vasopressin and thyroid during grave states of disease, when a patient is in critical condition.

참고문헌 (Reference)

1 Landry DW, "Vasopressin pressor hypersensitivity in vasodilatory septic shock" 25 : 1279-1282, 1997

2 Landry DW, "Vasopressin deficiency contributes to the vasodilation of septic shock" 95 : 1122-1125, 1997

3 Cohen J, "Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population" 32 : 1901-1905, 2006

4 Van der Poll T, "Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans" 261 : E457-465, 1991

5 Hotamisligil GS, "Tumor necrosis factor alpha: a key component of the obesity-diabetes link" 43 : 1271-1278, 1994

6 Van den Berghe G, "Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues" 47 : 599-612, 1997

7 Friesema EC, "Thyroid hormone transporters" 33 : 228-232, 2005

8 Vanhorebeek I, "The neuroendocrine response to critical illness is a dynamic process" 22 : 1-15, 2006

9 Vermes I, "The hypothalamic-pituitary-adrenal response to critical illness" 15 : 495-511, 2001

10 Marfella R, "The effect of acute hyperglycaemia on QTc duration in healthy man" 43 : 571-575, 2000

11 Wolfe R, "Testosterone and muscle protein metabolism" 75 (75): S55-59, 2000

12 Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008" 36 : 296-327, 2008

13 Bernton EW, "Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice" 239 : 401-404, 1988

14 Capes SE, "Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview" 355 : 773-778, 2000

15 Finlay WE, "Serum cortisol levels in severely stressed patients" 1 : 1414-1415, 1982

16 Peeters RP, "Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients" 88 : 3202-3211, 2003

17 Marik PE, "Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine" 36 : 1937-1949, 2008

18 Van den Berghe G, "Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone- releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness" 84 : 1311-1323, 1999

19 Russell DH, "Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine" 134 : 3027-3031, 1985

20 Rothwell PM, "Prediction of outcome in intensive care patients using endocrine parameters" 23 : 78-83, 1995

21 Schein RM, "Plasma cortisol levels in patients with septic shock" 18 : 259-263, 1990

22 Yen PM, "Physiological and molecular basis of thyroid hormone action" 81 : 1097-1142, 2001

23 Khaodhiar L, "Perioperative hyperglycemia, infection or risk?" 2 : 79-82, 1999

24 Beishuizen A, "Patterns of corticosteroid- binding globulin and the free cortisol index during septic shock and multitrauma" 27 : 1584-1591, 2001

25 Van den Berghe G, "Novel insights into the neuroendocrinology of critical illness" 143 : 1-13, 2000

26 Russell DH, "New aspects of prolactin and immunity: a lymphocyte- derived prolactin-like product and nuclear protein kinase C activation" 10 : 40-44, 1989

27 Rivier C, "Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin" 305 : 325-327, 1983

28 Hamrahian AH, "Measurements of serum free cortisol in critically ill patients" 350 : 1629-1638, 2004

29 Bartalena L, "Lack of nocturnal serum thyrotropin surge after surgery" 70 : 293-296, 1990

30 Dünser MW, "Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors" 31 : 1394-1398, 2003

31 Langouche L, "Intensive insulin therapy protects the endothelium of critically ill patients" 115 : 2277-2286, 2005

32 Van den Berghe G, "Intensive insulin therapy in the medical ICU" 354 : 449-461, 2006

33 van den Berghe G, "Intensive insulin therapy in the critically ill patients" 345 : 1359-1367, 2001

34 Peeters RP, "Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity" 90 : 6460-6465, 2005

35 Slag MF, "Hypothyroxinemia in critically ill patients as a predictor of high mortality" 245 : 43-45, 1981

36 Nilsson P, "Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: the Malm? Preventive Project" 253 : 136-145, 2003

37 Umpierrez GE, "Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes" 87 : 978-982, 2002

38 Noel GL, "Human prolactin and growth hormone release during surgery and other conditions of stress" 35 : 840-851, 1972

39 Pemberton PA, "Hormone binding globulins undergo serpin conformational change in inflammation" 336 : 257-258, 1988

40 Perner A, "High glucose impairs superoxide production from isolated blood neutrophils" 29 : 642-645, 2003

41 Chopra IJ, "Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses" 60 : 666-672, 1985

42 Venkatesh B, "Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study" 33 : 201-209, 2005

43 McIver B, "Euthyroid sick syndrome: an overview" 7 : 125-132, 1997

44 Wang C, "Effect of surgical stress on pituitary- testicular function" 9 : 255-266, 1978

45 Wang C, "Effect of acute myocardial infarction on pituitary-testicular function" 9 : 249-253, 1978

46 Van den Berghe G, "Dynamic neuroendocrine responses to critical illness" 23 : 370-391, 2002

47 Ben-Jonathan N, "Dopamine: a prolactin-inhibiting hormone" 6 : 564-589, 1985

48 Michalaki M, "Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery" 86 : 4198-4205, 2001

49 Romijn JA, "Decreased nocturnal surge of thyrotropin in nonthyroidal illness" 70 : 35-42, 1990

50 Ross R, "Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I" 35 : 47-54, 1991

51 Marik PE, "Critical illness-related corticosteroid insufficiency" 135 : 181-193, 2009

52 Rothwell PM, "Cortisol response to corticotropin and survival in septic shock" 337 : 582-583, 1991

53 Cooper MS, "Corticosteroid insufficiency in acutely ill patients" 348 : 727-734, 2003

54 Frankenfield DC, "Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients" 18 : 398-403, 1994

55 Bornstein SR, "Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs" 84 : 1729-1736, 1999

56 Sharshar T, "Circulating vasopressin levels in septic shock" 31 : 1752-1758, 2003

57 Dong Q, "Circulating immunoreactive inhibin and testosterone levels in men with critical illness" 36 : 399-404, 1992

58 Baxter RC, "Changes in the IGF-IGFBP axis in critical illness" 15 : 421-434, 2001

59 Bianco AC, "Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases" 23 : 38-89, 2002

60 Spratt DI, "Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated?" 15 : 479-494, 2001

61 Marik PE, "Adrenal insufficiency in the critically ill: a new look at an old problem" 122 : 1784-1796, 2002

62 Hindmarsh PC, "A sexually dimorphic pattern of growth hormone secretion in the elderly" 84 : 2679-2685, 1999

63 Hammond GL, "A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils" 71 : 34-39, 1990

64 Burchard K, "A review of the adrenal cortex and severe inflammation: quest of the “eucorticoid” state" 51 : 800-814, 2001

65 Van den Berghe G, "A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness" 85 : 183-192, 2000

66 Annane D, "A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin" 283 : 1038-1045, 2000